Search
for
Sort by
Research 481–510 of 1000+
- Evaluation of platelet-rich plasma on hair regrowth and lesional T-cell cytokine expression in alopecia areata: A randomized observer-blinded, placebo-controlled, split-head pilot study
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- COMPARISON OF EFFICACY OF BARICITINIB VERSUS METHOTREXATE THERAPY IN THE TREATMENT OF SEVERE ALOPECIA AREATA
- SALT Score Cards: Facilitating SALT Score Calculation in Alopecia Areata
- A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes
- Comparison of Efficacy of Autologous Platelet Rich Plasma Therapy With 5% Topical Minoxidil Spray in Treating Alopecia Areata: A Head-to-Head Assessment of Novel Approaches
- Does zinc have a role in alopecia areata? A clinic-biochemical study
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Response of alopecia areata of the beard to oral tofacitinib
- Study on Serum Vitamin D in Alopecia Areata Patients
- EVALUATION OF THE EFFICACY OF PIX LIQUIDA FOR ALOPECIA AREATA: A CASE REPORT
- Quantitative evaluation of carcinosin as an individualized remedy in pediatric alopecia areata using salt score and ludwig hair loss scales: A case report
- Signposts to the Promised Land in Alopecia Areata
- SALT score distribution with ritlecitinib treatment up to 24 months in alopecia areata
- Evaluation of vitamin D in pediatric alopecia areata: A case–control study of thirty patients in a tertiary care hospital
- Dupilumab's Bidirectional Effects on Alopecia Areata: A Systematic Review
- Dupilumab's Bidirectional Effects on Alopecia Areata: A Systematic Review
- Generative Artificial Intelligence Tools: Evaluating Ways to Automate Your SALT ( GATEWAYS ) Scoring of Alopecia Areata
- Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Management of alopecia areata: Updates and algorithmic approach
- Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety
- SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss
- Alefacept for Severe Alopecia Areata
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents